CELLECTIS S.A.

In News

Cellectis (NASDAQ: CLLS) schedules June 25, 2026 annual meeting in Paris - Stock Titan

Stock Titan - May 20, 2026

Cellectis Calls June 25, 2026 Shareholders’ Meeting to Approve 2025 Results and Broad Capital-Issuance Powers - TipRanks

TipRanks - May 21, 2026

Cellectis' Annual Shareholders General Meeting to be Held on June 25, 2026 - marketscreener.com

marketscreener.com - May 21, 2026

ALCLS: Lead allogeneic CAR-T therapies show strong efficacy and commercial potential - TradingView

TradingView - May 21, 2026

Cellectis files $200M mixed shelf offering - MSN

MSN - May 19, 2026

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update - Yahoo Finance

Yahoo Finance - Mar 19, 2026

Cellectis S.A. (EPA:ALCLS) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates - simplywall.st

simplywall.st - May 14, 2026

Gene-editing biotech Cellectis plans June 25 shareholder meeting in Paris - Stock Titan

Stock Titan - May 20, 2026

Cellectis S.A. (NASDAQ:CLLS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

MarketBeat - May 03, 2026

Cellectis Bets on Non-Viral Editing for Therapy Gains - CRISPR Medicine News

CRISPR Medicine News - Jan 28, 2026

Cellectis Reports Financial Results for the First Quarter 2026 - GlobeNewswire

GlobeNewswire - May 11, 2026

Cellectis S A : Notice of Meeting - Combined General Meeting of Shareholders - June 25, 2026 - marketscreener.com

marketscreener.com - May 20, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment